Announcements Trials

Browse Landscape

Phase

Phase 1 52 Phase 2 46 Phase 1/2 32 Phase NA 2 Phase EARLY_PHASE1 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 149 Lymphoma 60 Precursor Cell Lymphoblastic Leukemia-Lymphoma 47 Lymphoma, Large B-Cell, Diffuse 46 Leukemia 44 Lymphoma, Follicular 39 Lymphoma, Non-Hodgkin 35 Multiple Myeloma 33 Leukemia, Lymphocytic, Chronic, B-Cell 28 Leukemia, Myeloid, Acute 25 Burkitt Lymphoma 24 Neuroblastoma 21 Lymphoma, Large-Cell, Immunoblastic 16 Hodgkin Disease 16 Lymphoma, Mantle-Cell 14 Neoplasms 13 Triple Negative Breast Neoplasms 12 Lymphoma, B-Cell, Marginal Zone 11 Sarcoma 10 Inflammatory Breast Neoplasms 10 Rhabdomyosarcoma 8 Recurrence 8 Neoplasms, Plasma Cell 8 Myelodysplastic Syndromes 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Graft vs Host Disease 8 Lymphoma, T-Cell, Peripheral 7 Lymphoma, Large-Cell, Anaplastic 7 Leukemia, Biphenotypic, Acute 7 Lung Neoplasms 6

Interventions

Dacarbazine 25 Nivolumab 24 pembrolizumab 19 Ipilimumab 18 Interferon-alpha 10 trametinib 8 Vemurafenib 8 dabrafenib 7 aldesleukin 7 Temozolomide 7 Introns 7 Interferon alpha-2 6 Interleukin-2 5 Cisplatin 5 Chemotherapy, Adjuvant 5 talimogene laherparepvec 4 cemiplimab 4 binimetinib 4 Radiotherapy 4 Paclitaxel 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 sargramostim 3 encorafenib 3 cobimetinib 3 Vinblastine 3 Surgical Procedures, Operative 3 Specimen Handling 3 Sodium Chloride 3 Radiosurgery 3 Opdualag 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Melanoma × Cyclophosphamide × Clear all

NCT02278887 2025-03-10

TIL

The Netherlands Cancer Institute

Phase 3 Completed

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡